Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleOUTCOME AND TREATMENT OF RELAPSING EARLY PET NEGATIVE PATIENTS INCLUDED IN THE EORTC/LYSA/FIL H10 TRIAL ON STAGES I/II HODGKIN LYMPHOMA.AuthorsGac, A.; Chartier, L.; Girinsky, T.; Gotti, M.; Lazarovici, J.; Aurer, I.; Musto, P.; Damaj, G.; Federico, M.; Fortpied, C.; Raemaekers, J.; Meignan, M.; Hutchings, M.; Versati, A.; Andre, M.; Reman, O.SubjectsHODGKIN'S disease; TREATMENT effectiveness; COMBINED modality therapyPublicationHematological Oncology, 2019, Vol 37, p294ISSN0278-0232Publication typeArticleDOI10.1002/hon.104_2630